Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial

OBJECTIVE: To evaluate the efficacy and safety of galantamine in the treatment of Alzheimer's disease. DESIGN: Randomised, double blind, parallel group, placebo controlled trial. SETTING: 86 outpatient clinics in Europe and Canada. PARTICIPANTS: 653 patients with mild to moderate Alzheimer's disease...

Full beskrivning

Bibliografiska uppgifter

I publikationen:	BMJ
Huvudupphov:	Wilcock, Gordon K, Lilienfeld, Sean, Gaens, Els
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	BMJ Publishing Group 2000
Ämnen:	Papers
Länkar:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC27547/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11110737/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/bmj.321.7274.1445
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!